NEW YORK – Researchers in France have developed an analytical tool that helps identify gene expression signatures associated with patient response to cancer immunotherapies.
The method, called microenvironment cell populations (MCP)-counter, was featured in two studies published last week in Nature, which revealed an association between B cells in tertiary lymphoid structures (TLS), a part of the tumor microenvironment, and a response to immunotherapy in sarcomas and melanoma.